NCT04072315View on ClinicalTrials.gov

Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 13, 2020

Primary Completion Date

June 27, 2022

Study Completion Date

July 5, 2022

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

PLN-74809

PLN-74809

RADIATION

Knottin tracer

Radiotracer

Trial Locations (1)

94305

Stanford Medical Center, Palo Alto

Sponsors
All Listed Sponsors
collaborator

Stanford University

OTHER

lead

Pliant Therapeutics, Inc.

INDUSTRY

NCT04072315 - Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/ | Biotech Hunter | Biotech Hunter